Advertisement

Intensive Care Medicine

, Volume 37, Issue 4, pp 723–724 | Cite as

Acute right heart decompensation in a multiple trauma patient with chronic pulmonary hypertension

  • Steffen Weber-CarstensEmail author
  • Christian Lojewski
  • Sven Bercker
  • Klaus-Dieter Schaser
  • Suzanne Fateh-Moghadam
  • Udo Kaisers
Correspondence

Dear Editor,

We report a case of a 35-year-old woman with a history of long-standing idiopathic pulmonary arterial hypertension [PAH, resting mean pulmonary arterial pressure (mPAP) of 75 mmHg], who was involved in a serious motor vehicle accident. Over the previous 12 years, the patient sustained a high quality of life, as she was successfully treated with orally administered endothelin-receptor antagonist bosentan, continuous intravenous prostacyclin (epoprostenol) infusion through an ambulatory pump device, warfarin and diuretic agents [1, 2].

Clinical examination and diagnostic imaging after the accident revealed severe multiple trauma—involving thorax, pelvis, retroperitoneal bleeding and right kidney rupture (injury severity score of 41). Despite uninterrupted epoprostenol infusion, the newly placed pulmonary artery catheter revealed a mean PAP of 115 mmHg—far above the patient’s baseline. It was then decided to limit immediate surgical management to life- and limb-saving...

Keywords

Pulmonary Arterial Hypertension Bosentan Spontaneous Breathing Epoprostenol Hypoxic Pulmonary Vasoconstriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Supplementary material 1 (MPG 2623 kb)

References

  1. 1.
    Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351:1425–1436CrossRefPubMedGoogle Scholar
  2. 2.
    Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines (CPG) (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 34:1219–1263CrossRefPubMedGoogle Scholar
  3. 3.
    Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J, American College of Chest Physicians (2004) Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126:63S–71SCrossRefPubMedGoogle Scholar
  4. 4.
    Kaisers U, Busch T, Deja M, Donaubauer B, Falke KJ (2003) Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 31:S337–S342CrossRefPubMedGoogle Scholar
  5. 5.
    Cornet AD, Hofstra JJ, Swart EL, Girbes AR, Juffermans NP (2010) Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med 36:758–764CrossRefPubMedGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2011

Authors and Affiliations

  • Steffen Weber-Carstens
    • 1
    Email author
  • Christian Lojewski
    • 1
  • Sven Bercker
    • 2
  • Klaus-Dieter Schaser
    • 3
  • Suzanne Fateh-Moghadam
    • 4
  • Udo Kaisers
    • 2
  1. 1.Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité MitteCharité-Universitätsmedizin BerlinBerlinGermany
  2. 2.Deptartment of Anesthesiology and Intensive Care Medicine, Medical FacultyUniversity of LeipzigLeipzigGermany
  3. 3.Center for Musculoskeletal Surgery, Campus Virchow-KlinikumCharité-Universitätsmedizin BerlinBerlinGermany
  4. 4.Department of Cardiology and Cardiovascular MedicineUniversity Clinic of TuebingenTuebingenGermany

Personalised recommendations